2020 annual financial data
Travere Therapeutics 2020 Operating margin
Direct answer
Operating margin was -88.83%.
Operating income was -176,163,000 USD and net income was -169,431,000 USD.
Operating cash flow was -42,743,000 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 198,321,000 USD
- Operating income
- -176,163,000 USD
- Net income
- -169,431,000 USD
- Operating cash flow
- -42,743,000 USD